The Tribune notices that Haley’s yanked OSR#1 from the market

On Friday, I noted an e-mail circulating around the Internet in which disgraced University of Kentucky chemist and card-carrying general in the mercury militia, Boyd Haley, announced that he was suspending sales of his industrial chelator turned “antioxidant dietary supplement” OSR#1. Now, true to form, Trine Tsouderos at the Chicago Tribune has noticed and published a story on Haley’s decision, Controversial supplement to come off shelves:

Pharmacies are halting sales of OSR#1, a compound marketed as a dietary supplement to parents of children with autism, six weeks after the U.S. Food and Drug Administration called the product an unapproved new drug.

Several pharmacists told the Tribune they received an e-mail last week from Boyd Haley, president of the company that makes the product, informing them that OSR#1 would not be available after Thursday.

One online pharmacy, Forrest Health, posted this message: “CTI Science has voluntarily agreed to remove OSR#1® from the market effective Thursday, 29 July 2010.”

What’s truly depressing is that pharmacists would sell this stuff or that they’d be disappointed that it’s going off the market. Truly, money matters more than health to some of them.

In the meantime, the silence over at the chief cheerleader website for OSR#1, Age of Autism, remains deafening. It’s been over four days since the e-mail from Haley started circulating and bloggers noticed and started writing about it. Yet thus far…nothing. Maybe Kim Stagliano and company are hoping the story will go away if they ignore it long enough. Or maybe there’ll finally be a post there in the morning.

I’m not holding my breath, though.